$RYTM

Rhythm Pharmaceuticals Announces Major Breakthrough in Phase 3 Trial for Rare Form of Obesity

$RYTM Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company focused on rare neuroendocrine diseases, has shared exciting news from its…